![]() |
市場調查報告書
商品編碼
2032877
事後緊急避孕藥市場報告:按類型、分銷管道和地區分類(2026-2034 年)Emergency Contraceptive Pills Market Report by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2026-2034 |
||||||
2025年全球事後緊急避孕藥市場規模達6.266億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到8.386億美元,2026年至2034年的複合年成長率為3.19%。市場成長的主要促進因素包括民眾對避孕和計劃生育的認知不斷提高、政府和非政府組織(NGO)的支持措施,以及近年來非荷爾蒙類事後緊急避孕藥(ECP)的研發。
事後緊急避孕藥(ECP)是指用於預防意外懷孕的避孕措施。這些藥物使用合成激素,例如levonorgestrel,透過延遲排卵、改變子宮內膜狀態來阻止受精。緊急避孕廣泛應用於常規避孕失敗、無保護性行為後、錯過常規避孕措施、性侵受害者。它們安全、經濟、易於取得且使用方便,能夠有效預防意外懷孕,且不會造成長期不孕問題,以避免墮胎。此外,緊急避孕也有助於改善生殖健康管理,增強女性自主權,減輕焦慮和壓力,並將副作用降至最低。
大眾對避孕和計劃生育意識的提高是市場成長的主要驅動力。緊急避孕藥(ECP)作為一種安全、便利、舒適的緊急避孕方法,被女性廣泛使用,它能有效預防意外懷孕,保護隱私,並將副作用和併發症的風險降至最低。此外,由於無保護性行為和性侵犯導致的意外懷孕發生率不斷上升,該產品的廣泛使用也促進了市場成長。政府和非政府組織(NGO)採取的支持措施,旨在提高公眾意識、普及相關知識並提供便利的緊急避孕途徑,這些措施也對市場成長產生了積極影響。近年來,非荷爾蒙類事後緊急避孕藥(ECP)的研發進展,例如醋酸烏利司他(一種阻斷體內孕激素受體且副作用少於傳統levonorgestrel片的藥物),也推動了市場成長。此外,全球對女性健康和福祉日益成長的關注推動了該產品的普及,也促進了市場成長。同時,無需處方箋即可購買的非處方藥(OTC)需求不斷成長,也促進了市場成長。此外,製造商透過社群媒體、網紅行銷、電視廣告和名人代言等管道所進行的積極推廣和品牌宣傳宣傳活動也促進了市場成長。其他預計推動市場成長的因素還包括消費者購買力的提升、積極的研發活動以及透過電子商務平台便捷地獲取產品。
The global emergency contraceptive pills market size reached USD 626.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 838.6 Million by 2034, exhibiting a growth rate (CAGR) of 3.19% during 2026-2034. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.
Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.
The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women's health, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.